FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling
The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Abstract
Although the liver is generally considered the main site of production of FGF21 (fibroblast growth factor-21), high FGF21 levels have been found to be associated with neuromuscular mitochondrial genetic diseases, and there are indications that the muscle may be a relevant site of FGF21 production under conditions of muscular mitochondrial stress. In the present study, we found that expression and release of FGF21 was associated with myogenic differentiation, and we identified MyoD as a major controller of FGF21 gene transcription. Mimicking mitochondrial dysfunction using respiratory chain/oxidative phosphorylation inhibitors resulted in enhanced expression and release of FGF21 by muscle cells. The increased production of reactive oxygen species, subsequent induction of p38 MAPK (mitogen-activated protein kinase) and activation of an ATF2 (activating transcription factor 2)-binding site at the proximal promoter region of the FGF21 gene was found to be a major mechanism linking mitochondrial dysfunction with enhanced FGF21 gene transcription in myogenic cells. The myogenic factor MyoD was required for the induction of FGF21 gene transcription by mitochondrial dysfunction, thus explaining the preferential response of muscle cells to mitochondrial dysfunction-induced FGF21 expression and secretion. FGF21 release by muscle cells in response to mitochondrial alterations may represent a physiological mechanism by which the sensing of internal energetic status by muscles results in the release of FGF21 to favour systemic metabolic adaptations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fibroblast growth factor-21 is a widely expressed protein with a broad mode of action, including the regulation of carbohydrate and fatty acid metabolism283 and may be considered as a myokine due to its secretion from muscle cells.284”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [284]
Citations
Cites
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Kim, K. H., Jeong, Y. T., Oh, H., Kim, S. H., Cho, J. M., Kim, Y.-N., Kim, S. S., Kim, D. H., Hur, K. Y., Kim, H. K., et al. (2013) · Nature Medicine · doi:10.1038/nm.3014 · Cited by 774
Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue
Hondares, E., Iglesias, R., Giralt, A., Gonzalez, F. J., Giralt, M., Mampel, T., & Villarroya, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215889 · Cited by 623
Self-citationSuomalainen, A., Elo, J. M., Pietiläinen, K. H., Hakonen, A. H., Sevastianova, K., Korpela, M., Isohanni, P., Marjavaara, S. K., Tyni, T., Kiuru-Enari, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70155-7 · Cited by 427
FGF21 is an Akt‐regulated myokine
Izumiya, Y., Bina, H. A., Ouchi, N., Akasaki, Y., Kharitonenkov, A., & Walsh, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.021 · Cited by 415
Research works printed but not linked: 1
- Camara, 2005, The cross-talk among mitochondrial activity, reactive oxygen species production and apoptosis in skeletal muscle. A role for uncoupling protein-3?, 189
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Brown adipose tissue as a secretory organ
Villarroya, F., Cereijo, R., Villarroya, J., & Giralt, M. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.136 · Cited by 673
Self-citationRole of Myokines in Regulating Skeletal Muscle Mass and Function
Lee, J. H., & Jun, H.-S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00042 · Cited by 432
OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance
Pereira, R. O., Tadinada, S. M., Zasadny, F. M., Oliveira, K. J., Pires, K. M. P., Olvera, A., Jeffers, J., Souvenir, R., Mcglauflin, R., Seei, A., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696179 · Cited by 211
“Studies have linked diverse signaling pathways with FGF21 induction in muscle; those include activation of AKT (Izumiya et al , 2008), ER stress, activation of ATF4 (Kim et al , 2013), oxidative stress (Ribas et al , 2014), and more recently activation of mTORC1 (Guridi et al , 2015).”
Montero, R., Yubero, D., Villarroya, J., Henares, D., Jou, C., Rodríguez, M. A., Ramos, F., Nascimento, A., Ortez, C. I., Campistol, J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148709 · Cited by 176
“Drugs were used at concentrations that did not cause significant cytotoxicity in myotubes and caused an induction of FGF-21 gene expression and release [18].”
InfluentialSelf-citationFibroblast growth factor-21, energy balance and obesity
Giralt, M., Gavaldà‐Navarro, A., & Villarroya, F. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.018 · Cited by 161
Self-citationSkeletal muscle energy metabolism in obesity
Mengeste, A. M., Rustan, A. C., & Lund, J. (2021) · Obesity · doi:10.1002/oby.23227 · Cited by 141
Mitochondria Retrograde Signaling and the UPRmt: Where Are We in Mammals?
Arnould, T., Michel, S., & Renard, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818224 · Cited by 133
“results in chronic lipid recruitment and mobilization from adipose tissue and triggers ketogenesis in the liver [52,53].”
BackgroundZhang, F., Yu, L., Lin, X., Cheng, P., He, L., Li, X., Lu, X., Tan, Y., Yang, H., Cai, L., et al. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1155 · Cited by 130
FGF21 and Cardiac Physiopathology
Planavila, A., Redondo-Angulo, I., & Villarroya, F. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00133 · Cited by 123
Self-citationTanaka, N., Takahashi, S., Zhang, Y., Krausz, K. W., Smith, P. B., Patterson, A. D., & Gonzalez, F. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.02.012 · Cited by 120
Geller, S., Arribat, Y., Netzahualcoyotzi, C., Lagarrigue, S., Carneiro, L., Zhang, L., Amati, F., López‐Mejía, I. C., & Pellerin, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.004 · Cited by 122
“Since Fgf21 expression was shown to depend on ROS production and p38-MAPK signaling in muscle and adipocytes (Jeanson et al., 2016; Ribas et al., 2014), we studied the capacity of tanycytes to produce ROS, activate p38-MAPK, and express Fgf21 in response to palmitate (Figures 3G–3N).”
BackgroundIntegrated stress response stimulates FGF21 expression: Systemic enhancer of longevity
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.08.009 · Cited by 97
“There is abundant evidence indicating that FGF21 is a myokine which can be induced by several stresses and subsequently secreted into the circulation [37,65,66] (Fig.”
BackgroundThe Lives and Times of Brown Adipokines
Villarroya, F., Gavaldà‐Navarro, A., Peyrou, M., Villarroya, J., & Giralt, M. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.10.005 · Cited by 98
Self-citationAyuso, M., Fernández, A., Núñez, Y., Benítez, R., Isabel, B., Barragán, C., Fernández, A. I., Rey, A. I., Medrano, J. F. F., Cánovas, Á., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145162 · Cited by 94
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
So, W. Y., & Leung, P. S. (2016) · Medicinal Research Reviews · doi:10.1002/med.21390 · Cited by 92
“The engineered FGF21, FGF21(1-171)-WD22, is functionally indistinguishable from native FGF21 in terms of signaling activation, receptor binding specificity, and induction of adipose glucose uptake, but has increased potency with the more tolerant C-terminal modification.”
BackgroundSamms, R. J., Cheng, C. C., Kharitonenkov, A., Gimeno, R. E., & Adams, A. C. (2016) · Endocrinology · doi:10.1210/en.2015-1722 · Cited by 72
Spann, R. A., Morrison, C. D., & den Hartigh, L. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.802541 · Cited by 82
Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice
Morovat, A., Weerasinghe, G. R., Nesbitt, V., Hofer, M., Agnew, T., Quaghebeur, G., Sergeant, K., Fratter, C., Guha, N., Mirzazadeh, M., et al. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6080080 · Cited by 82
“In trying to elucidate the mechanism linking FGF-21 and mitochondrial stress, other studies have found myocytic FGF-21 expression to be controlled by myogenic factor MyoD and to be driven by mitochondrial reactive oxygen species [21].”
BackgroundWu, Y., Ren, Z., Zhu, S., Wu, Y., Wang, G., Zhang, H., Chen, W., He, Z., Ye, X.-L., & Zhai, Q. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00786-2 · Cited by 69
Lactate induces FGF21 expression in adipocytes through a p38-MAPK pathway
Jeanson, Y., Ribas, F., Galinier, A., Arnaud, E., Ducos, M., André, M., Chenouard, V., Villarroya, F., Casteilla, L., & Carrière, A. (2016) · Biochemical Journal · doi:10.1042/bj20150808 · Cited by 61
Self-citationLiu, X., Wang, Y., Hou, L., Xiong, Y., & Zhao, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25735 · Cited by 56
“In addition to the MyoD site previously reported (Ribas et al., 2014), we found many other potential MyoD sites located in this region as shown in Figure 5G.”
BackgroundSkeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
Sun, H., Sherrier, M. C., & Li, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.625287 · Cited by 59
Fibroblast growth factor 21 in chronic kidney disease
Suassuna, P. G. D. A., de Paula, R. B., Sanders‐Pinheiro, H., Moe, O. W., & Hu, M. C. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0550-y · Cited by 61
Mitochondrial retrograde signaling in the nervous system
Hunt, R. J., & Bateman, J. M. (2017) · FEBS Letters · doi:10.1002/1873-3468.12890 · Cited by 47
Altered Circadian Rhythm and Metabolic Gene Profile in Rats Subjected to Advanced Light Phase Shifts
Herrero, L., Valcárcel-Jiménez, L., da Silva, C. A., Albert, N., Díez-Noguera, A., Cambras, T., & Serra, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122570 · Cited by 51
“To study the circadian pattern, motor activity data were represented in double-plotted actograms at modulo 24h, and a Chi squared periodogram [26] was calculated to determine the main circadian periodicity.”
BackgroundMethodIzaguirre, M., Gil, M. J., Monreal, I., Montecucco, F., Frühbeck, G., & Catalán, V. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0866-3 · Cited by 44
Fasting blood glucose levels in patients with different types of diseases
Zhang, Q., Zhao, G., Yang, N., & Zhang, L. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.01.004 · Cited by 50
ANGPTL6 expression is coupled with mitochondrial OXPHOS function to regulate adipose FGF21
Kang, S., Yi, H., Choi, M. J., Ryu, M. J., Jung, S.-B., Chung, H. K., Chang, J. Y., Kim, Y. K., Lee, S. E., Kim, H. W., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0549 · Cited by 37
Modulation of energy balance by fibroblast growth factor 21
Ramos, D. C., & Aguilar-Salinas, C. A. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0023 · Cited by 38
“FGF21 expression in heart [34, 78], and skeletal muscle [79, 80], occurs mainly and may be only after mitochondrial dysfunction, exerting cardioprotective effects attenuating heart remodeling, inflammation, and oxidative stress [81].”
BackgroundSestili, P., Ambrogini, P., Barbieri, E., Sartini, S., Fimognari, C., Calcabrini, C., Diaz, A. R., Guescini, M., Polidori, E., Luchetti, F., et al. (2016) · Amino Acids · doi:10.1007/s00726-015-2161-4 · Cited by 35
“oxidative stress) is known to inhibit myogenic cell proliferation and differentiation (Ardite et al. 2004; Barbieri et al. 2011; Hansen et al. 2007; Langen et al. 2002; Ribas et al. 2014; Sestili et al. 2009; Singh et al. 2014) and to promote wasting of myofibers (Buck and Chojkier 1996; Zaccagnini et al.”
BackgroundInfluentialAltered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners
Campderrós, L., Sánchez‐Infantes, D., Villarroya, J., Nescolarde, L., Bayés‐Genís, A., Cereijo, R., Roca, E., & Villarroya, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.550102 · Cited by 36
“In this sense, the secretion of GDF15 in muscle parallels that of fibroblast growth factor-21 (FGF21), which was recently proposed to be a biomarker of diseases caused by mitochondrial DNA mutations (Suomalainen et al., 2011; Ribas et al., 2014).”
BackgroundSelf-citationArias‐Calderón, M., Casas, M., Balanta‐Melo, J., Morales, C., Hernández, N., Llanos, P., Jaimovich, E., & Buvinic, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1059020 · Cited by 33
Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease
Kakoty, V., Sarathlal, K. C., Tang, R.-D., Yang, C. H., Dubey, S. K., & Taliyan, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110145 · Cited by 29
Zhou, Y. G., Wu, Y., Qin, Y., Liu, L., Wan, J., Zou, L., Zhang, Q., Zhu, J., & Mi, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159191 · Cited by 28
Bond, S. T., King, E. J., Walker, S., Yang, C., Liu, Y., Liu, K. H., Zhuang, A., Jurrjens, A. W., Fang, H., Formosa, L. E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57299-3 · Cited by 30
Hormonal factors in the control of the browning of white adipose tissue
Hu, J., & Christian, M. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0017 · Cited by 23
“Furthermore, FGF21 is also released by the liver and muscle [50], [51], [52].”
BackgroundViola, H. M., Johnstone, V., Szappanos, H. C., Richman, T. R., Tsoutsman, T., Filipovska, A., Semsarian, C., Seidman, J. G., Seidman, C. E., & Hool, L. C. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2015.12.001 · Cited by 26
“mitochondrial dysfunction in myocytes (43,44), we measured FGF21 in circulating blood from the mice.”
MethodWeight gain during the menopause transition: Evidence for a mechanism dependent on protein leverage
Simpson, S. J., Raubenheimer, D., Black, K. I., & Conigrave, A. D. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17290 · Cited by 33
Sestili, P., Barbieri, E., & Stocchi, V. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150722102342 · Cited by 26
Fibroblast Growth Factor 21: A Fascinating Perspective on the Regulation of Muscle Metabolism
Li, S., Chen, J., Wei, P., Zou, T., & You, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316951 · Cited by 23
“This effect, in turn, promotes the secretion of a large amount of FGF21, suggesting a crucial mediating role in ameliorating skeletal muscle oxidation and relieving endoplasmic reticulum stress [75,87].”
BackgroundInfluentialLiu, X., Wang, Y., Zhao, S., & Li, X. (2017) · BioMed Research International · doi:10.1155/2017/1648715 · Cited by 20
“FGF21 is associated with myogenic differentiation and regulated by myogenic factor MyoD; also, FGF21 is involved in myofiber type transformation [32, 33].”
BackgroundMoure, R., Domingo, P., Villarroya, J., Gasa, L., Gallego-Escuredo, J. M., Quesada‐López, T., Morón‐Ros, S., Maroto, A. F., Mateo, G. M., Domingo, J. C., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00029-18 · Cited by 20
“For studies on human skeletal muscle cells, LHCN-M2 myoblastic cells were differentiated to myotubes as previously reported (23).”
BackgroundSelf-citationOxidative Phosphorylation Dysfunction Modifies the Cell Secretome
Garrido-Pérez, N., Vela‐Sebastián, A., López‐Gallardo, E., Emperador, S., Iglesias, E., Meade, P., Jimenez-Mallebrera, C., Montoya, J., Bayona‐Bafaluy, M. P., & Ruiz‐Pesini, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093374 · Cited by 16
“Previous studies have shown that ROS production was involved in the induction of FGF21 expression by experimental mitochondrial dysfunction [68].”
BackgroundPlacental fibroblast growth factor 21 is not altered in late-onset preeclampsia
Nitert, M. D., Scholz‐Romero, K., Kubala, M. H., McIntyre, D. H., Callaway, L. K., & Barrett, H. L. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0006-3 · Cited by 13
“FGF21 is synthesized and secreted from the liver, adipose tissue, pancreatic β-cells, skeletal muscle, white blood cells and possibly cerebrospinal fluid [9-12].”
BackgroundLow Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease
Miyazaki, Y., Saita, E., Kishimoto, Y., Ibe, S., Seki, T., Miura, K., Sugihara, N., Ikegami, Y., Ohmori, R., Kondo, K. N., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.41731 · Cited by 13
Wu, G., Wu, S., Yan, J., Gao, S., Zhu, J., Yue, M., Li, Z., & Tan, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.834967 · Cited by 13
“Fibroblast growth factor 21 (FGF21) is a member of the FGF family, and is expressed in heart, kidney and liver (6, 7).”
BackgroundHui, Q., Huang, Z., Pang, S., Yang, X., Li, J., Yu, B., Tang, L., Li, X., & Wang, X. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9470-y · Cited by 12
Elia, I., Realini, G., Mauro, V. D., Borghi, S., Bottoni, L., Tornambè, S., Vitiello, L., Weiss, S. J., Chiariello, M., Tamburrini, A., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200215r · Cited by 12
Lactate induces expression and secretion of fibroblast growth factor-21 by muscle cells
Villarroya, J., Campderrós, L., Ribas‐Aulinas, F., Carrière, A., Casteilla, L., Giralt, M., & Villarroya, F. (2018) · Endocrine · doi:10.1007/s12020-018-1612-6 · Cited by 10
Self-citationRama, K., Jahagirdar, V., & Sanyal, A. J. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s560034 · Cited by 7
“Notably, hepatic FGF21 is predominantly endocrine in function, whereas extrahepatic expression often reflects localized autocrine or paracrine signalling, highlighting organ-specific differences in both magnitude and functional role.”
Potential role of Akt in the regulation of fibroblast growth factor 21 by berberine
Hirai, T., Wang, W., Murono, N., Iwasa, K., & Inoue, M. (2023) · Journal of Natural Medicines · doi:10.1007/s11418-023-01755-1 · Cited by 4
“FGF21 expression was recently shown to be regulated by endoplasmic reticulum stress and additional intracellular stress signaling pathways [24, 55].”
Jackson, T. C., Herrmann, J. R., Fink, E. L., Au, A. K., & Kochanek, P. M. (2023) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000003424 · Cited by 4
“FGF21 cellular expression is increased by mitochondrial reactive oxygen species (67).”
BackgroundShira, K. A., Thornton, K. J., Murdoch, B. M., Becker, G. M., Chibisa, G. E., & Murdoch, G. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299975 · Cited by 4
Lee, B., Jo, D., Park, J., Kim, O. Y., & Song, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38534 · Cited by 4
Fibroblast growth factor 21: new insights from human studies
Hansen, J. S., & Plomgaard, P. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000084 · Cited by 2
Alieva, A. M., Baikova, I. E., Reznik, E. V., Valiev, R. K., Akhmatov, I. Z., Arakelyan, R. A., Saryev, M. N., & Nikitin, I. G. (2022) · Russian Medicine · doi:10.17816/medjrf108900 · Cited by 2
The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity
Guha, A., Si, Y., Smith, R., Singh, B. K., Zogu, B., Yadav, A., Smith, K. A., Kazamel, M., Jiang, N., Ho, R., et al. (2025) · Aging · doi:10.18632/aging.206298 · Cited by 7
“In addition to a rescue effect, we also found that FGF21 promoted myogenesis, including enhanced proliferation and differentiation of C2C12 myoblasts and in human primary myoblasts (Figure 8), as observed by other investigators [88, 89].”
Zhang, X., Zhao, Y., Liang, X., Zhang, L., Li, K., Sun, Z., & Zhao, Y. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13775 · Cited by 1
“The stimulatory role of mitochondrial stress in FGF21 expression is also supported by previous studies.(8,11,41) Therefore, it indicates that ALA induces mitochondrial stress to upregulate FGf21 expression in HepG2 cells.”
BackgroundLi, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00001-9 · Cited by 1
FGF21 Conducts a Metabolic Orchestra and Fat Is a Key Player
Whittle, A. J. (2016) · Endocrinology · doi:10.1210/en.2016-1193 · Cited by 1
The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicityPreprint
Guha, A., Si, Y., Smith, R., Kazamel, M., Jiang, N., Smith, K. A., Thalacker‐Mercer, A. E., Singh, B. K., Ho, R., Andrabi, S. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.11.611693 · Cited by 1
Veloso, M. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-28092021-102847
Duque, E. J. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-19102023-133130
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00007-x
Bond, S. T., King, E. J., Walker, S., Yang, C., Liu, Y., Liu, K. H., Zhuang, A., Jurrjens, A. W., Fang, H., Formosa, L. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.02.597064
Zheng, L., Sasaki, T., Ni, L., Takahashi, Y., Yamauchi, Y., Shimizu, M., & Sato, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.18.638653
Gilad, N., Darlyuk‐Saadon, I., Mohanam, M. P., & Engelberg, D. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111338
Fu, S., Meng, Y., Liang, K., & Feng, M. (2026) · Biomolecules · doi:10.3390/biom16091238
“Although the liver is generally considered the major source of circulating FGF21, skeletal muscle can also induce FGF21 expression in selected contexts, including acute insulin stimulation, mitochondrial dysfunction, and impaired mitochondrial fatty acid oxidation [220–222].”
Metadata
- Authors
- Ribas, F., Villarroya, J., Hondares, E., Giralt, M., & Villarroya, F.
- Affiliations
- Department of Biochemistry and Molecular Biology, and Institute of Biomedicine (IBUB), University of Barcelona, Avda Diagonal 645, E-08028 Barcelona, Spain
- Universitat Autònoma de Barcelona (ES)
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Villarroya, Joan
- Hondares, Elayne
- Giralt, Marta
- Villarroya, Francesc
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2014-09-22
- Volume
- 463
- Issue
- 2
- Pages
- 191-199
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2332400050
- Cited by
- 69
- References
- 37
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 9 · 2016: 13 · 2015: 9
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- FGF21, muscle cells, MyoD, mitochondrial dysfunction, myogenesis, gene transcription, reactive oxygen species, p38 MAPK, ATF2, mitochondrial stress, energy sensing, metabolic adaptation
- MeSH terms
- Animals, Cell Differentiation, Cell Line, Fibroblast Growth Factors, Gene Expression Regulation, Humans, Mitochondria, Transcription, Genetic, Signal Transduction, Reactive Oxygen Species, MyoD Protein, Muscle Cells, p38 Mitogen-Activated Protein Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.